Seeing Is Believing
with an average price target of $7.27. This is a potential upside of $7.27 (0%) from yesterday's end of day stock price of $0.
Acceleron Pharma's activity chart (see below) currently has 157 price targets and 89 ratings on display.
Analysts average stock forecasts to be materialized ratio is 84.21% with an average time for these price targets to be met of 171.11 days.
Most recent stock forecast was given by DANIELLE BRILL from RAYMOND JAMES on 08-Oct-2021. First documented stock forecast 14-Aug-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 years 1 months 13 days ago
(08-Oct-2021)
15/16 (93.75%)
$7.9 (4.59%)
248
Hold
$180
$1.25 (0.70%)
$180
3 years 1 months 13 days ago
(08-Oct-2021)
0/4 (0%)
$34.21 (26.40%)
Hold
$180
$1.25 (0.70%)
$168
3 years 1 months 20 days ago
(01-Oct-2021)
14/15 (93.33%)
$5.65 (3.24%)
303
Hold
$180
$1.25 (0.70%)
$122
3 years 1 months 20 days ago
(01-Oct-2021)
4/5 (80%)
$5.65 (3.24%)
133
Hold
$180
$1.25 (0.70%)
$146
3 years 1 months 20 days ago
(01-Oct-2021)
7/8 (87.5%)
$5.65 (3.24%)
119
What is XLRN (Acceleron Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on XLRN (Acceleron Pharma) with a proven track record?
Which analyst has the most public recommendations on XLRN (Acceleron Pharma)?
Which analyst is the currently most bullish on XLRN (Acceleron Pharma)?
Which analyst is the currently most reserved on XLRN (Acceleron Pharma)?